119 related articles for article (PubMed ID: 3229065)
41. Preoperative prognostic variables and the impact of postoperative adjuvant therapy on the outcomes of Stage IB or II cervical carcinoma patients with or without pelvic lymph node metastases: an analysis of 891 cases.
Lai CH; Hong JH; Hsueh S; Ng KK; Chang TC; Tseng CJ; Chou HH; Huang KG
Cancer; 1999 Apr; 85(7):1537-46. PubMed ID: 10193944
[TBL] [Abstract][Full Text] [Related]
42. Intratumoral lymphatic vessel density and clinicopathologic features of patients with early-stage cervical cancer after radical hysterectomy.
Zaganelli FL; Carvalho FM; Almeida BG; Bacchi CE; Goes JC; Calil MA; Baracat EC; Carvalho JP
Int J Gynecol Cancer; 2010 Oct; 20(7):1225-31. PubMed ID: 21135594
[TBL] [Abstract][Full Text] [Related]
43. Outcome and prognostic factors of laparoscopic radical hysterectomy and pelvic lymphadenectomy in 148 patients with stage IB1 cervical cancer.
Yan X; Li G; Shang H; Lin F; Yang X; Zheng F
Int J Gynecol Cancer; 2012 Feb; 22(2):286-90. PubMed ID: 22146764
[TBL] [Abstract][Full Text] [Related]
44. The case for completing the lymphadenectomy when positive lymph nodes are found during radical hysterectomy for cervical carcinoma.
Kenter GG; Hellebrekers BW; Zwinderman KH; van de Vijver M; Peters LA; Trimbos JB
Acta Obstet Gynecol Scand; 2000 Jan; 79(1):72-6. PubMed ID: 10646820
[TBL] [Abstract][Full Text] [Related]
45. Pattern of lymph node metastasis and the optimal extent of pelvic lymphadenectomy in FIGO stage IB cervical cancer.
Lee JM; Lee KB; Lee SK; Park CY
J Obstet Gynaecol Res; 2007 Jun; 33(3):288-93. PubMed ID: 17578357
[TBL] [Abstract][Full Text] [Related]
46. Early cervical cancer and parametrial involvement: is it significant?
Steed H; Capstick V; Schepansky A; Honore L; Hiltz M; Faught W
Gynecol Oncol; 2006 Oct; 103(1):53-7. PubMed ID: 16516279
[TBL] [Abstract][Full Text] [Related]
47. Postoperative pelvic radiotherapy for cervical cancer patients with positive parametrial invasion.
Uno T; Ito H; Isobe K; Kaneyasu Y; Tanaka N; Mitsuhashi A; Suzuka K; Yamazawa K; Shigematsu N; Itami J
Gynecol Oncol; 2005 Feb; 96(2):335-40. PubMed ID: 15661218
[TBL] [Abstract][Full Text] [Related]
48. [Clinicopathologic characteristics and risk factors for lung metastasis after radical hysterectomy in early-stage cervical cancer].
Zheng A; Chen Y; Fang J; Zhang Y
Zhonghua Fu Chan Ke Za Zhi; 2015 Mar; 50(3):204-9. PubMed ID: 26268411
[TBL] [Abstract][Full Text] [Related]
49. Retrospective analysis for predictors of parametrial involvement in IB cervical cancer.
Kubota S; Kobayashi E; Kakuda M; Matsuzaki S; Ueda Y; Yoshino K; Kimura T
J Obstet Gynaecol Res; 2019 Mar; 45(3):679-685. PubMed ID: 30565810
[TBL] [Abstract][Full Text] [Related]
50. Radical hysterectomy for FIGO stage IIB cervical cancer: clinicopathological characteristics and prognostic evaluation.
Kasamatsu T; Onda T; Sawada M; Kato T; Ikeda S
Gynecol Oncol; 2009 Jul; 114(1):69-74. PubMed ID: 19398126
[TBL] [Abstract][Full Text] [Related]
51. Prognostic factors affecting the outcome of early cervical cancer treated with radical hysterectomy and post-operative adjuvant therapy.
Liu MT; Hsu JC; Liu WS; Wang AY; Huang WT; Chang TH; Pi CP; Huang CY; Huang CC; Chou PH; Chen TH
Eur J Cancer Care (Engl); 2008 Mar; 17(2):174-81. PubMed ID: 18302655
[TBL] [Abstract][Full Text] [Related]
52. [Wertheim-operation: 5-year survival of 501 consecutive patients with cervical cancer].
Papp Z; Csapó Z; Mayer A; Hupuczi P
Orv Hetil; 2006 Mar; 147(12):537-45. PubMed ID: 16696377
[TBL] [Abstract][Full Text] [Related]
53. Prognostic factors in stage IB-IIB cervical adenocarcinoma patients treated with radical hysterectomy and pelvic lymphadenectomy.
Kodama J; Seki N; Masahiro S; Kusumoto T; Nakamura K; Hongo A; Hiramatsu Y
J Surg Oncol; 2010 Apr; 101(5):413-7. PubMed ID: 20127891
[TBL] [Abstract][Full Text] [Related]
54. Quality and quantity metrics of pelvic lymph node metastasis and risk of para-aortic lymph node metastasis in stage IB-IIB cervical cancer.
Matsuo K; Grubbs BH; Mikami M
J Gynecol Oncol; 2018 Jan; 29(1):e10. PubMed ID: 29185268
[No Abstract] [Full Text] [Related]
55. Early stage cervical cancer: adjuvant treatment in negative lymph node cases.
Sartori E; Tisi G; Chiudinelli F; La Face B; Franzini R; Pecorelli S
Gynecol Oncol; 2007 Oct; 107(1 Suppl 1):S170-4. PubMed ID: 17765298
[TBL] [Abstract][Full Text] [Related]
56. Postoperative radiation therapy for stage IB-IIB carcinoma of the cervix with poor prognostic factors.
Uno T; Ito H; Itami J; Yasuda S; Isobe K; Hara R; Sato T; Minoura S; Shigematsu N; Kubo A
Anticancer Res; 2000; 20(3B):2235-9. PubMed ID: 10928184
[TBL] [Abstract][Full Text] [Related]
57. [Clinical analysis of 32 cases with neuroendocrine carcinoma of the uterine cervix in early-stage disease].
Wang Z; Wu L; Yao H; Sun Y; Li X; Li B; Zhang R; Ma S; Huang M
Zhonghua Fu Chan Ke Za Zhi; 2015 Mar; 50(3):198-203. PubMed ID: 26268410
[TBL] [Abstract][Full Text] [Related]
58. Prediction model of pelvic lymph node metastasis in early stage cervical cancer and its clinical value.
Sun JR; Zhang YN; Sun XM; Feng SY; Yan M
Minerva Chir; 2011 Dec; 66(6):537-45. PubMed ID: 22233660
[TBL] [Abstract][Full Text] [Related]
59. Predictive Factors of Pelvic Lymph Node Metastasis in Early-Stage Cervical Cancer.
Nanthamongkolkul K; Hanprasertpong J
Oncol Res Treat; 2018; 41(4):194-198. PubMed ID: 29562222
[TBL] [Abstract][Full Text] [Related]
60. Radical hysterectomy for stage IIB cervical cancer: a review.
Suprasert P; Srisomboon J; Kasamatsu T
Int J Gynecol Cancer; 2005; 15(6):995-1001. PubMed ID: 16343175
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
